Inventions, Government-owned; availability for licensing,

[Federal Register: June 28, 2004 (Volume 69, Number 123)]

[Notices]

[Page 36162-36163]

From the Federal Register Online via GPO Access [wais.access.gpo.gov]

[DOCID:fr28jn04-114]

DEPARTMENT OF VETERANS AFFAIRS

Office of Research and Development

Government Owned Invention Available for Licensing

AGENCY: Office of Research and Development, Veterans Affairs.

ACTION: Notice of Government Owned Invention Available for Licensing.

SUMMARY: The invention listed below is owned by the U.S. Government as represented by the Department of Veterans Affairs, and is available for licensing in accordance with 35 U.S.C. 207 and 37 CFR part 404 and/or CRADA Collaboration under 15 U.S.C. 3710a to achieve expeditious commercialization of results of federally funded research and development. Foreign patents are filed on selected inventions to extend market coverage for U.S. companies and may also be available for licensing.

FOR FURTHER INFORMATION CONTACT: Technical and licensing information on the invention may be obtained by writing to: Robert W. Potts, Department of Veterans Affairs, Director Technology Transfer Program, Office of Research and Development , 810 Vermont Avenue NW., Washington, DC 20420; fax: 202-254-0473; e-mail at bob.potts@hq.med.va.gov. Any request for information should include the

Number and Title for the relevant invention as indicated below. Issued patents may be obtained from the

[[Page 36163]]

Commissioner of Patents, U.S. Patent and Trademark Office, Washington, DC 20231.

SUPPLEMENTARY INFORMATION: The invention available for licensing is: U.S. Provisional Patent Application No. 60/545,532 ``Method of Ameliorating or Abrogating the Effects of a Neurodegenerative Disorder, such as Huntington's Disease, by Sodium Butyrate Chemotherapy.''

Dated: June 21, 2004. Anthony J. Principi, Secretary, Department of Veterans Affairs.

[FR Doc. 04-14578 Filed 6-25-04; 8:45 am]

BILLING CODE 8320-01-P